FCMT
APYX icon

Founders Capital Management (Texas)’s Apyx Medical APYX Stock Holding History

Founders Capital Management (Texas)’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-5,000
Closed -$22K – 307
2018
Q2 		$22K Hold
5,000
– – 0.02% 175
2018
Q1 		$15K Hold
5,000
– – 0.01% 237
2017
Q4 		$13K Buy
5,000
+1,000
+25% +$3.12K 0.01% 253
2017
Q3 		$14K Hold
4,000
– – 0.01% 239
2017
Q2 		$10K Hold
4,000
– – 0.01% 269
2017
Q1 		$11K Buy
+4,000
New +$13.3K 0.01% 270

Other funds holding APYX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
MAG
Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return
HK
Horizon Kinetics New York $3.06B AUM 5.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Founders Capital Management (Texas)'s APYX Position: Q3 2018 in Review

Founders Capital Management (Texas) sold out of Apyx Medical (APYX) in Q3 2018, closing a stake of 5,000 shares — an estimated $22K sold.

Founders Capital Management (Texas) first reported a position in APYX in Q1 2017 and held it in 6 quarters. The position peaked at $22K in Q2 2018. 56 funds tracked by Wall St. Rank hold APYX as of Q3 2018.

  • Founders Capital Management (Texas) reported no remaining Apyx Medical position as of Q3 2018 after selling out during the quarter.
  • Founders Capital Management (Texas) sold 5,000 Apyx Medical shares in Q3 2018, an estimated $22K.
  • Founders Capital Management (Texas) first reported a position in Apyx Medical in Q1 2017 and held it in 6 quarters.
  • Founders Capital Management (Texas)'s Apyx Medical position peaked at $22K in Q2 2018.
  • 56 funds tracked by Wall St. Rank held Apyx Medical as of Q3 2018.

Based on Founders Capital Management (Texas)'s 13F filing for Q3 2018, filed 5 Oct 2018.